Medical weight management | New York

Foundayo oral GLP-1 evaluation in New York

Foundayo contains orforglipron, an oral GLP-1 receptor agonist approved for long-term weight management in qualifying adults. It is a different molecule from semaglutide and tirzepatide.

Foundayo oral GLP-1

How Foundayo oral GLP-1 works

Orforglipron activates the GLP-1 receptor to help regulate appetite and glucose. Unlike oral semaglutide, Foundayo can be taken with or without food. It still requires a medication review because interactions can affect treatment.

Eligibility: Foundayo oral GLP-1

Foundayo is approved for adults with obesity or overweight with at least one weight-related condition, with reduced-calorie eating and increased activity. It is not an approved pediatric product or a dedicated PCOS treatment. A clinician determines whether it fits your health and goals.

What to expect: Foundayo oral GLP-1

Review other medicines, pregnancy plans, and gastrointestinal history. The labeled starting dose is 0.8 mg once daily, with at least 30 days before each step. Swallow one tablet whole daily and do not double doses. The clinician reviews tolerability before increasing treatment. Confirm a refill and follow-up plan.

Preparing for your appointment

Bring your weight and treatment history, medicines and supplements, relevant glucose, kidney, and lipid results, and the exact product you have used before. Mention previous side effects, eye disease, eating difficulties, and pregnancy plans. If insurance denied treatment, bring the denial and plan details.

Risks and when to seek help

Review a personal or family history of medullary thyroid cancer, MEN 2, severe stomach-emptying problems, pancreatitis, gallbladder disease, allergies, and pregnancy plans before treatment. Nausea, vomiting, constipation, or diarrhea can occur. Persistent severe abdominal pain or inability to keep fluids down needs emergency department assessment now. Call 911 for breathing difficulty, a severe allergic reaction, loss of consciousness or unsafe travel. Tell the anesthesia team about treatment before a procedure. Do not combine GLP-1 medicines or change the dose yourself. Foundayo can affect oral contraceptive reliability. Use a non-oral method or add a barrier method for 30 days after starting and after each dose increase. Review simvastatin and CYP3A4-related interactions with the prescriber. Stop treatment when pregnancy is recognized.

Follow-up and treatment review

Review weight trend, appetite, food and fluid intake, bowel symptoms, and treatment tolerability. Check glucose and adjust other diabetes medicines with the prescriber when relevant. Agree on how to contact the team between visits and what to do if a refill is delayed. Continued treatment depends on benefit, safety, access, and your goals.

Appointments, costs and coverage

Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.

Questions about your care

What is Foundayo?

Foundayo contains orforglipron, an oral GLP-1 receptor agonist approved for long-term weight management in qualifying adults. It is a different molecule from semaglutide and tirzepatide. FDA approval does not confirm pharmacy stock or a Nao Medical prescribing service. Orforglipron activates the GLP-1 receptor to help regulate appetite and glucose. Unlike oral semaglutide, Foundayo can be taken with or without food. It still requires a medication review because interactions can affect treatment.

Does Foundayo have to be taken on an empty stomach?

Foundayo can be taken with or without food. Wegovy tablets and Ozempic tablets/Rybelsus require an empty stomach with no more than four ounces of water and a wait of at least 30 minutes before food, other drinks, or oral medicines. Follow the exact product’s instructions. Do not transfer fasting rules between brands.

What is the starting dose?

Can I take Foundayo with another GLP-1 medicine?

Do not combine or overlap GLP-1 medicines or brands yourself. Product labels do not recommend this combination. The prescriber should review the exact current treatment and write any switch plan.

Does Foundayo affect birth-control pills?

Foundayo can reduce oral contraceptive reliability through delayed stomach emptying. Use a non-oral contraceptive method or add a barrier method for 30 days after starting and for 30 days after every dose increase. Discuss the method with your clinician.

Is Foundayo available in the United States?

Yes. Lilly announced US commercial availability of Foundayo on April 9, 2026, and LillyDirect offers prescription access. As of October 9, 2026, that establishes a US dispensing route, not stock at every pharmacy or a guaranteed Nao prescription. Ask the pharmacy about your prescribed strength, payment and refill timing before starting.

Is a Foundayo prescription guaranteed after an evaluation?

The evaluation does not guarantee a prescription, dose change, authorization, or medicine supply. The clinician reviews your records and health before recommending treatment. Review other medicines, pregnancy plans, and gastrointestinal history. The labeled starting dose is 0.8 mg once daily, with at least 30 days before each step. Swallow one tablet whole daily and do not double doses. The clinician reviews tolerability before increasing treatment. Confirm a refill and follow-up plan.

Is orforglipron FDA-approved, and when was it approved?

Yes. The FDA approved orforglipron under the brand Foundayo on April 1, 2026, for long-term weight management in adults with obesity, or overweight with a weight-related medical condition, alongside diet and activity changes. The approval is for this specific product and purpose. It does not make every orforglipron research preparation approved or establish a separate type 2 diabetes indication.

How much does orforglipron, sold as Foundayo, cost?

As of October 9, 2026, Lilly’s 30-day self-pay price is $149 for 0.8 mg. Through December 31, 2026, the temporary prices are $149 for 2.5 mg and $199 for 5.5 mg. The 9 mg price is $299. Regular pricing for 14.5 and 17.2 mg is $349; a $299 purchase offer requires refilling within 45 days of the previous delivery to keep the offer. Eligibility, taxes and fees can affect the bill. These are manufacturer program prices. Confirm your prescribed strength and current terms with the pharmacy, and visit or test charges separately.

How do you pronounce orforglipron?

Lilly gives the pronunciation as “or-for-GLIP-ron,” with the emphasis on GLIP. Orforglipron is the ingredient in Foundayo. Use the brand and ingredient names when confirming a prescription with your clinician or pharmacist.

Is orforglipron a peptide?

No. Orforglipron is a small-molecule, nonpeptide GLP-1 receptor agonist. It acts on the GLP-1 receptor but is a different molecule from semaglutide or tirzepatide. Its approved tablet product is Foundayo. “Nonpeptide” does not mean that it has no risks or can be combined freely with other GLP-1 medicines.

Medical sources

What the current U.S. label says

Who may be considered

The clinician should confirm the adult weight-management indication, treatment history, current medicines, and diabetes and eye history. The review also covers gastrointestinal or gallbladder concerns, kidney and liver context, pregnancy and procedure plans, and personal or family history relevant to the boxed warning.

How it is used

Foundayo is swallowed whole once daily, with or without food. The current label starts at 0.8 mg daily and increases in stages at intervals of at least 30 days according to response and tolerability, up to a labeled maximum of 17.2 mg daily.

What needs monitoring

Follow-up should address response, gastrointestinal effects, hydration and kidney concerns, symptoms of pancreatitis or gallbladder disease, blood glucose when relevant, eye history in diabetes, interacting oral medicines, and pregnancy prevention counseling.

What a careful evaluation must resolve

Clinical fit

Safety and follow-up

Access and care logistics

Before starting Foundayo, review eligibility, other medicines, contraception, dose changes, costs, side effects and follow-up with your clinician.

Important limits

Discussing your care

An evaluation may lead to another medicine, more testing, a referral, or no medication change.

No coverage promise

The health plan and dispensing pharmacy make coverage and fulfillment decisions. Prior authorization may be required.

No location assumption

The clinic cards below show places to start an evaluation. They do not prove that a product is stocked, dispensed, taught, or administered at that site.

Evaluation locations across New York